Stoke Therapeutics, Inc. (STOK)

28.05 -0.65 (-2.26%) USD  |  NASDAQ  |  Jan 20, 14:18
More

Stoke Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for STOK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Insmed, Inc. Upgrade
Aldeyra Therapeutics, Inc. --
Mirum Pharmaceuticals, Inc. Upgrade
Moderna, Inc. Upgrade